The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Interrelationship of primary and secondary mutations in gastrointestinal stromal tumors during TKI therapy.
Peter Hohenberger
No relevant relationships to disclose
Ming Wang
No relevant relationships to disclose
Carina Heydt
No relevant relationships to disclose
Alexander Marx
No relevant relationships to disclose
Ulrich Ronellenfitsch
No relevant relationships to disclose
Eva Wardelmann
No relevant relationships to disclose